Chinese Herbal medicine for Severe nevel coronavirus pneumonia (COVID-19): a Randomized Controlled Trial

Phase 1

Recruiting

• Conditions: novel coronavirus pneumonia (COVID-19)

• Registration Number: ITMCTR2000002946
• Lead Sponsor: Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1) Aged >= 18 years;
2) Meet the diagnostic criteria of severe pneumonia patients with new coronavirus;
3) The informed consent form.

Exclusion Criteria

1) Severe basic diseases that affect survival, including: uncontrolled malignant tumors with multiple metastases that cannot be removed, hematological diseases, cachexia, active bleeding, severe malnutrition, HIV, etc.;
2) Obstructive pneumonia caused by lung tumors, severe pulmonary interstitial fibrosis, alveolar proteinosis, allergic reaction alveolitis;
3) Previous immunosuppressive agents within 6 months before study entry or recipients of a solid-organ or bone marrow transplant;
4) Pregnant or lactating women;
5) Researchers believe that patients may have other factors affecting the efficacy or safety evaluation of this study.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Critically ill patients (%);

Secondary Outcome Measures

Name	Time	Method
Antibiotic use;Oxygenation index;PCT;